Expert Interview
A Third Look at the efficacy of Mavacamten as a treatment of hypertrophic cardiomyopathy
Ticker(s): BMY, LIANInstitution: Queens Medical Center
-
Advanced Heart Failure director at Queen’s Medical Center and faculty at the University of Hawai’i; formerly the medical director of the mechanical circulatory support program at Stanford. Board certified in Advanced Heart failure/transplant cardiology and Echocardiography.
-
Currently manages 20 patients with cardiac amyloidosis.
-
Led a research program focusing on improving outcomes in left ventricular assist device patients and reducing heart failure readmissions, while also serving as site principal investigator for numerous multi-center clinical trials
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
